Khaled M Elamin
Overview
Explore the profile of Khaled M Elamin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahma M, Suhandi C, Mohammed A, El-Rayyes A, Elamin K, Sulastri E, et al.
Int J Nanomedicine
. 2025 Feb;
20:1865-1880.
PMID: 39975418
As many as 48.0% of the global population suffers from disabilities caused by oral conditions. These conditions encompass dental caries, periodontal diseases, oral cancers, and other pathologies affecting the hard...
2.
Fitriani N, Wilar G, Narsa A, Elamin K, Wathoni N
Stem Cells Cloning
. 2025 Jan;
18():1-13.
PMID: 39816853
Objective: Chronic wounds are a common clinical problem that necessitate the exploration of novel regenerative therapies. We report a method to investigate the in vitro wound healing capacity of an...
3.
Alnagar A, Motawea A, Elamin K, Abu Hashim I
Pharm Dev Technol
. 2024 Oct;
29(9):1016-1032.
PMID: 39392049
Traditional chemotherapeutic drugs lack optimal efficacy and invoke severe adverse effects in cancer patients. Polydatin (PD), a phytomedicine, has gradually gained attention due to its antitumor activity. However, its low...
4.
Herdiana Y, Febrina E, Nurhasanah S, Gozali D, Elamin K, Wathoni N
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204388
Chitosan nanoparticles (CSNPs) are promising vehicles for targeted and controlled drug release. Recognized for their biodegradability, biocompatibility, low toxicity, and ease of production, CSNPs represent an effective approach to drug...
5.
Narsa A, Suhandi C, Afidika J, Ghaliya S, Elamin K, Wathoni N
Dermatol Res Pract
. 2024 Aug;
2024:5551774.
PMID: 39184919
Currently, retinoids are known for their abundant benefits to skin health, ranging from reducing signs of aging and decreasing hyperpigmentation to treating acne. However, it cannot be denied that there...
6.
Wathoni N, Suhandi C, Elamin K, Lesmana R, Hasan N, Mohammed A, et al.
Int J Nanomedicine
. 2024 Aug;
19:8091-8113.
PMID: 39161361
The current treatments for wound healing still exhibit drawbacks due to limited availability at the action sites, susceptibility to degradation, and immediate drug release, all of which are detrimental in...
7.
Vitamia C, Iftinan G, Latarissa I, Wilar G, Cahyanto A, Elamin K, et al.
Drug Des Devel Ther
. 2024 Apr;
18:1297-1312.
PMID: 38681204
Recurrent aphthous stomatitis (RAS) refers to a sore and frequently recurring inflammation of the oral tissues, distinguished by the presence of small ulcers that cause significant discomfort and cannot be...
8.
Yuniarsih N, Chaerunisaa A, Elamin K, Wathoni N
Int J Nanomedicine
. 2024 Mar;
19:2733-2754.
PMID: 38505165
Nanohydrogels (NH) are biodegradable polymers that have been extensively studied and utilized for various biomedical applications. Drugs in a topical medication are absorbed via the skin and carried to the...
9.
Wathoni N, Suhandi C, Ghassani Purnama M, Mutmainnah A, Nurbaniyah N, Syafra D, et al.
Infect Drug Resist
. 2024 Mar;
17:791-805.
PMID: 38444772
Untreated topical infections can become chronic, posing serious health issues. Optimal skin adherence is crucial in addressing such infections. In this context, chitosan and alginate emerge as promising candidates for...
10.
Aldeeb M, Wilar G, Suhandi C, Elamin K, Wathoni N
Int J Nanomedicine
. 2024 Jan;
19:825-844.
PMID: 38293608
Nanosuspensions have garnered recent attention as a promising strategy for mitigating the bioavailability challenges of hydrophobic drugs, particularly those characterized by poor solubility in both aqueous and organic environments. Addressing...